CAG Recap & More

Conagra Brands, Inc. CAG – Recap 

With the markets ripping again yesterday, one of the options ideas we had zeroed in on produced some really nice gain opportunities for us. We signaled the CAG 07/02 $33.50-34.50 Calls, and two out of three of those contracts logged double-bag gains on the day.

Here are the total ranges and possible profits that these calls provided:

CAG 07/02 $33.50-34.50 Calls
$33.50: 1.15-2.15 (+87%)
$34: .77-1.76 (+129%)
$34.50: .55-1.35 (+145%)


Fresh Ideas:
FDX 07/02 $149-155 Calls
STZ 07/02 $175-180 Calls

OncoCyte Corp. OCX

On OCX yesterday, we noticed a drastic change as the stock fell off a cliff on news that it would discontinue development of its DetermaDx liquid biopsy test. Purely from a technical perspective, we have to take notice when a stock gets chopped by half and falls to near annual lows in one session.

It leaves a lot of future opportunity for a bounceback on the table, so we’re going to signal a long term idea in the options chain, and begin monitoring the OCX 11/20 $2.50 Calls.

Extended Watchlist:

AMC Options Recap & More

AMC Entertainment Holdings Inc. AMC – Recap

Despite a rather bearish day for the markets in general, our bullish AMC options idea worked out quite nicely for us yesterday. We had signaled a single contract set with a June expiration, and got instant double-bag results.

Our specific idea was the AMC 06/19 $4 Calls, and they traded in a range from .55-1.15, for total possible gains of up to 109% on the day.

The company announced it won’t be playing Universal Studios films in the future as a result of NBCUniversal’s plans to release movies direct-to-home on-demand. It will be interesting to see how this affects our idea going forward, but as it stands, we’re happy with the single-session performance it recorded yesterday.

Fresh Options Ideas:

All of the following plays have reported earnings this morning, so as usual, we’re going to try to use the corresponding volatility to our advantage in hopes of seeing some nice gain opportunities:

AZN Weekly $52-53 Calls
MA Weekly $272.50-277.50 Calls
BA Weekly $138-140 Calls

Extended Watchlist:

BSGM Update & More

BioSig Technologies, Inc. BSGM

We are still tracking BSGM as we open up another trading week. If you recall one of our recent reports where we mentioned having talked about this stock on multiple occasions (April 7thApril 22nd) you can see that we’ve preen pretty hot on its trail through its whole recent run.

Our observed low on BSM came in at 3.45 shortly following our initial alert on it, and as of today in the premarket, we’re seeing high marks of as much as 9.25. That works out to an overall increase of in a matter of roughly three weeks.

The company has also just submitted an investigational new drug application with the FDA for its orally administered coronavirus treatment. We’re going to be very interested to continue keeping an eye on the activity in BSGM which has now been running hard for a full seven sessions.

Options Ideas 

Facebook’s announcement that it would be entering the multi-user conferencing arena, has us temporarily bullish on FB and bearish on ZM. We will formulate some quick-strike options ideas accordingly;

FB Weekly $192.50-197.50 Calls
ZM Weekly $160-155 Puts

Extended Watchlist: